Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003707 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 | 22 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jun 28, 2012 | clinicaltrials |
| NCT00424632 | Phase 1 Study Of Aurora Kinase Inhibitor PF-03814735 In Patients With Advanced Solid Tumors | completed | Phase 1 | 57 | PfizerINDUSTRY | 2 | Jun 25, 2012 | clinicaltrials |
| NCT00086723 | In Vivo Angiostatin Generation Using Tissue Plasminogen Activator and Captopril in Treating Patients With Progressive Metastatic Cancer | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 11, 2012 | clinicaltrials |
| NCT00004914 | Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT01247168 | An Open-Label, Dose-Escalation Study of AZD2461 | completed | Phase 1 | 75 | AstraZenecaINDUSTRY | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00004913 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Northwestern UniversityOTHER | 1 | Jun 1, 2012 | clinicaltrials |
| NCT00004912 | Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | May 30, 2012 | clinicaltrials |
| NCT00237627 | Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 107 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 18, 2012 | clinicaltrials |
| NCT00004212 | DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas | completed | Phase 1 | — | Daiichi SankyoINDUSTRY | 1 | May 16, 2012 | clinicaltrials |
| NCT00077077 | DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | — | Daiichi SankyoINDUSTRY | 1 | May 16, 2012 | clinicaltrials |
| NCT00320073 | Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 41 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 16, 2012 | clinicaltrials |
| NCT00586560 | Karenitecin in Pediatric Patients With Refractory or Recurrent Solid Tumors N10010)(KTN10010) | completed | Phase 1 | 15 | Baylor College of MedicineOTHER | 1 | May 15, 2012 | clinicaltrials |
| NCT00839631 | Dose Escalation Study of EC D-3263 HCl in Advanced Solid Tumors | completed | Phase 1 | 23 | DendreonINDUSTRY | 1 | May 2, 2012 | clinicaltrials |
| NCT00573690 | Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors | completed | Phase 1 | 31 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Apr 24, 2012 | clinicaltrials |
| NCT00741234 | A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine | completed | Phase 1 | 85 | S*BIOINDUSTRY | 2 | Apr 23, 2012 | clinicaltrials |
| NCT00389922 | Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 22 | University of California, DavisOTHER | 1 | Apr 19, 2012 | clinicaltrials |
| NCT01106248 | QT Interval Prolongation Study of Eribulin Mesylate (E7389) in Patients With Advanced Solid Tumors | completed | Phase 1 | 26 | Eisai LimitedINDUSTRY | 1 | Apr 13, 2012 | clinicaltrials |
| NCT00969410 | A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases | completed | Phase 1 | 19 | AVEO Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 12, 2012 | clinicaltrials |
| NCT00636545 | Genasense as a 2-hour Intravenous Infusion in Subjects With Solid Tumors | completed | Phase 1 | 25 | Genta IncorporatedINDUSTRY | 1 | Apr 6, 2012 | clinicaltrials |
| NCT00307255 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors | completed | Phase 1 | 18 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Apr 4, 2012 | clinicaltrials |
| NCT00949559 | Pharmacodynamics (PD) and Pharmacokinetics (PK) Study of EP-100 in Advanced Solid Tumors | completed | Phase 1 | 38 | Esperance Pharmaceuticals IncINDUSTRY | 1 | Apr 4, 2012 | clinicaltrials |
| NCT00253474 | PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma | completed | Phase 1 | 36 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 29, 2012 | clinicaltrials |
| NCT00703378 | Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic Cycle | completed | Phase 1 / Phase 2 | 33 | National University Hospital, SingaporeOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT01072890 | Temsirolimus and Pazopanib in Patients With Advanced Solid Tumors | completed | Phase 1 | 8 | University of California, DavisOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT01469052 | First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors | completed | Phase 1 | 36 | PfizerINDUSTRY | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00019513 | Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas | completed | Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 23, 2012 | clinicaltrials |
| NCT01381341 | To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib. | completed | Phase 1 | 13 | AbbottINDUSTRY | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00054223 | Study of Decision Making in Patients Participating in Phase I Clinical Trials | completed | N/A | 250 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 16, 2012 | clinicaltrials |
| NCT00734890 | Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 18 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 16, 2012 | clinicaltrials |
| NCT00019019 | Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas | completed | Phase 1 | 70 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00030108 | Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy | completed | Phase 1 | 30 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00031941 | CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy | completed | Phase 1 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00036959 | ABT-751 in Treating Young Patients With Refractory Solid Tumors | completed | Phase 1 | 90 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00043030 | Evaluating Patient Participation in Phase I Clinical Trials | completed | N/A | 120 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00088868 | 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma | completed | Phase 1 | 40 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00095914 | Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00303940 | Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors | completed | Phase 1 | 26 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00356980 | TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 60 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00387608 | ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer | completed | Phase 1 | 23 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00899691 | Study of Hair Samples From Patients With Cancer | completed | — | 190 | National Institutes of Health Clinical Center (CC)NIH | 0 | Mar 15, 2012 | clinicaltrials |
| NCT00908908 | A Study to Determine the Metabolism and Elimination of Carbon-14 Labeled Eribulin Acetate (14C-Eribulin) in Patients With Advanced Solid Tumors | completed | Phase 1 | 6 | Eisai Inc.INDUSTRY | 1 | Mar 9, 2012 | clinicaltrials |
| NCT00021047 | Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor | completed | Phase 1 / Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00062049 | Interleukin-7 in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 30 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00079469 | Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who Continue to Smoke | completed | N/A | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00559039 | Effects of Fetal, Infant, and Early Childhood Exposures on Adult Cancer Risk in Women | completed | — | 128,700 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00589381 | Fenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or Lymphoma | completed | Phase 1 | 30 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00520000 | Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 47 | UNC Lineberger Comprehensive Cancer CenterOTHER | 0 | Mar 6, 2012 | clinicaltrials |
| NCT00606814 | Phase I Study of IPI-504 and Docetaxel in Patients With Advanced Solid Tumors | completed | Phase 1 | 60 | Infinity Pharmaceuticals, Inc.INDUSTRY | 1 | Mar 6, 2012 | clinicaltrials |
| NCT00737555 | A Study of the Safety and Tolerability of the Addition of CHR-2797 to Paclitaxel in Patients With Advanced or Refractory Tumours | completed | Phase 1 | 23 | Chroma TherapeuticsINDUSTRY | 1 | Feb 15, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Jun 28, 2012source: clinicaltrials